IMMU-02. LOCOREGIONAL HER2CAR T CELLS FOR PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: PRECLINICAL EFFICACY TO TOLERABILITY IN FIRST PATIENT

Chimeric antigen receptor (CAR) T cell therapy provides a broadly applicable, targeted, yet pathway-independent, intervention for pediatric central nervous system (CNS) tumors. We have optimized the efficacy and specificity of a HER2-targeted CAR with an extracellular target-specific scFv domain der...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Vitanza, Nicholas, Johnson, Adam, Beebe, Adam, Gust, Juliane, Hauptman, Jason, Hoeppner, Corrine, Wilson, Ashley, Perez, Francisco, Pinto, Navin, Orenta, Rimas, Finn, Laura, Gardner, Rebecca, Park, Julie, Jensen, Michael
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Immunology/Immunotherapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477237/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.123
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares